Cargando…

Therapeutic monitoring of mood stabilizers in bipolar disorder

INTRODUCTION: Efficacy of lithium is well documented in the literature, making it the gold standard treatment. However, its use declines with the advent of anticonvulsants. This raises the question about monitoring of mood stabilizers in practice. OBJECTIVES: The aims of this study were to determine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Falfel, D., Ammar, H. Ben, Hamdi, G., Khelifa, E., Mnif, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475992/ http://dx.doi.org/10.1192/j.eurpsy.2021.1296

Ejemplares similares

Uric acid levels among Tunisian patients with bipolar disorder during different phases of illness
por: Falfel, D., et al.
Publicado: (2022)

COVID-19 pandemic and first episode of psychosis: Clinical characteristics
por: Brahmi, L., et al.
Publicado: (2021)

Psychotic relapse from COVID-19 pandemic: Clinical features
por: Brahmi, L., et al.
Publicado: (2021)

Effectiveness of mood stabilizers in prophylactic treatment of bipolar disorder
por: Khattech, D., et al.
Publicado: (2023)

Childhood maltreatment and clinical response to mood stabilizers in patients with bipolar disorder
por: Attianese, N., et al.
Publicado: (2023)

Burnout among pharmacists in Tunisia during COVID-19 pandemic
por: Falfel, D., et al.
Publicado: (2022)

Antipsychotics and mood stabilizers on risk for hepatic failure in people with schizophrenia and bipolar disorder
por: Tascón Guerra, M.F., et al.
Publicado: (2022)

Bipolar disorder and peripartum mood episodes: Epidemiology and clinical correlates
por: Aragno, E., et al.
Publicado: (2021)

Testostérone and Positive Dimension in Schizophrenia
por: Bouguerra, I., et al.
Publicado: (2023)

Prolactin and Family Psychiatric History in Schizophrenia
por: Bouguerra, I., et al.
Publicado: (2023)

Gambling disorder and suicidal behavior : A case report :
por: Abassi, B., et al.
Publicado: (2022)

Neuromolecular Etiology of Bipolar Disorder: Possible Therapeutic Targets of Mood Stabilizers
por: Lee, Jung Goo, et al.
Publicado: (2022)

Aggressive behavior in patients hospitalised for a psychotic relapse
por: Bouguerra, I., et al.
Publicado: (2023)

Prolactin levels and agressive behaviour in men with Schizophrenia
por: Bouguerra, I., et al.
Publicado: (2023)

Bipolar mood disorder and treatment-resistant depression
por: Rybakowski, Janusz K
Publicado: (2010)

Pharmacogenomics of Mood Stabilizers in the Treatment of Bipolar Disorder
por: Squassina, Alessio, et al.
Publicado: (2010)

Covid-19 Barrier gestures for patients with schizophrenia: A therapeutic “dead end”?
por: Bouguerra, I., et al.
Publicado: (2022)

What if Cannabis has a medical relevance in psychiatric disorders?
por: Abassi, B., et al.
Publicado: (2022)

Control charts for monitoring mood stability as a predictor of severe episodes in patients with bipolar disorder
por: Vazquez-Montes, Maria D. L. A., et al.
Publicado: (2018)

Nonlinear time-series approaches in characterizing mood stability and mood instability in bipolar disorder
por: Bonsall, M. B., et al.
Publicado: (2012)

Electroencephalographic frequency activity of patients with bipolar disorder
por: Mnif, M., et al.
Publicado: (2023)

Trajectories of adherence to mood stabilizers in patients with bipolar disorder
por: Bauer, M., et al.
Publicado: (2019)

RNA Biomarkers in Bipolar Disorder and Response to Mood Stabilizers
por: Pisanu, Claudia, et al.
Publicado: (2023)

Mood Stabilisers, but for Lithium, are not stabilizing Moods! Bipolar Disorders: Clinical conundrums 2
por: Reddy, M. S., et al.
Publicado: (2017)

Stabilization Beyond Mood: Stabilizing Patients With Bipolar Disorder in the Various Phases of Life
por: Simonetti, Alessio, et al.
Publicado: (2020)

Providing Incentives on a Smartphone-Based Mood Relapse Warning Application among Patients with Bipolar Disorder
por: Lin, Y.-H., et al.
Publicado: (2023)

Impact of sunlight exposure on the age of onset of bipolar disorder
por: Arfaoui, N., et al.
Publicado: (2022)

THE RELATIONSHIP BETWEEN RESIDUAL MOOD SYMPTOMS, DISPOSITIONAL MINDFULNESS, AND QUALITY OF LIFE IN BIPOLAR DISORDER
por: Piazza, F. P., et al.
Publicado: (2023)

The role of neuronal network synchronization as a potential biomarker for bipolar disorder
por: Mnif, M., et al.
Publicado: (2023)

Hamlet’s augury: how to manage discontinuation of mood stabilizers in bipolar disorder
por: Qureshi, Mutahira M., et al.
Publicado: (2021)

Daily longitudinal self-monitoring of mood variability in bipolar disorder and borderline personality disorder
por: Tsanas, A., et al.
Publicado: (2016)

Mood dynamics in bipolar disorder
por: Moore, Paul J, et al.
Publicado: (2014)

Mood stability versus mood instability in bipolar disorder: A possible role for emotional mental imagery
por: Holmes, Emily A., et al.
Publicado: (2011)

First psychotic episode, related to COVID‐19 pandemic, in a patient with tuberous sclerosis complex
por: Brahmi, Lina, et al.
Publicado: (2021)

Borderline Personality Disorder: Bipolarity, Mood Stabilizers and Atypical Antipsychotics in Treatment
por: Belli, Hasan, et al.
Publicado: (2012)

General pharmacokinetic/pharmacodynamic concepts of mood stabilizers in the treatment of bipolar disorder
por: Ware, Kenric, et al.
Publicado: (2016)

Aripiprazole Augmentation to Mood Stabilizers for Obsessive-Compulsive Symptoms in Bipolar Disorder
por: Di Salvo, Gabriele, et al.
Publicado: (2020)

Bipolar disorder, cardiac comorbidity and therapeutic impasse: A case report
por: Bouslama, I., et al.
Publicado: (2021)

Experience of Using a Smartphone Mood Relapse Warning Application among Patients with Bipolar Disorders: A Qualitative Inquiry
por: Lin, E.C.-L., et al.
Publicado: (2022)

Distant mood monitoring for depressive and bipolar disorders: a systematic review
por: van der Watt, A. S. J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_orramb5arvualn077of8jf36ar